Cowealth Medical Holding Co., Ltd. (TPEX:4745)
Taiwan
· Delayed Price · Currency is TWD 19.50
-1.05 (-5.11%)
Mar 9, 2026, 1:30 PM CST
Cowealth Medical Holding Revenue
Cowealth Medical Holding had revenue of 771.55M TWD in the quarter ending September 30, 2025, a decrease of -25.66%. This brings the company's revenue in the last twelve months to 3.41B, down -20.86% year-over-year. In the year 2024, Cowealth Medical Holding had annual revenue of 4.19B, down -12.88%.
Revenue (ttm)
3.41B
Revenue Growth
-20.86%
P/S Ratio
0.44
Revenue / Employee
n/a
Employees
n/a
Market Cap
1.51B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 4.19B | -619.85M | -12.88% |
| Dec 31, 2023 | 4.81B | -813.80M | -14.46% |
| Dec 31, 2022 | 5.63B | 486.62M | 9.47% |
| Dec 31, 2021 | 5.14B | 417.81M | 8.85% |
| Dec 31, 2020 | 4.72B | 56.81M | 1.22% |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
| Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Rossmax International | 3.80B |
| Bioptik Technology Incorporation | 829.18M |
| Taiwan Biomaterial | 203.27M |
| OK Biotech | 1.64B |
| Diamond Biotechnology | 698.11M |
| AViTA | 896.85M |
| Wiltrom | 311.77M |
| Wellell | 2.39B |